Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Scientific Acquires IntegenX

NEW YORK (GenomeWeb) – Thermo Fisher Scientific said on Friday that it has acquired forensic DNA testing firm IntegenX for an undisclosed amount.

IntegenX, headquartered in Pleasanton, California, has been developing rapid DNA testing technology for human identification for use in forensics and law enforcement. In 2015, the company launched the RapidHit ID System, which allows users to profile individuals from buccal swabs in less than two hours using short tandem repeat (STR) chemistries sold by Thermo Fisher. In addition, it sells the RapidHIT System, its first-generation STR-based human identification system that is also compatible with Thermo Fisher's STR kits.

IntegenX's technology is currently used in government laboratories of 17 countries to generate forensic DNA profiles.

According to Thermo Fisher, IntegenX complements and enhances its existing human identification product portfolio, including reagents, qPCR systems, and capillary electrophoresis systems.

"The development of rapid DNA technology provides law enforcement with the ability to generate results while a suspect is still in custody," said Rosy Lee, vice president of human identification at Thermo Fisher, in a statement. The increased demand for such testing from law enforcement agencies, she said, "aligns with our strategy to expand our leadership position in the human identification market."

"Combining our market-leading technologies with Thermo Fisher's scale and depth of capabilities will benefit both our customers and our employees," said Robert Schueren, president and CEO of IntegenX, in a statement.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.